Context Therapeutics Investor Presentation Deck slide image

Context Therapeutics Investor Presentation Deck

Clinical Development Strategy Blocking cancer growth by combining antiestrogen and antiprogestin therapies Stimulus Cancer Driver Outcome 7 Context Therapeutics Inc. - Sept. 2022 Antiestrogens aromatase inhibitors, SERM, SERCA, injectable SERD, oral SERD 1 Estrogen Cell Survival Proliferation Antiprogestin ONA-XR 1 Progesterone Stemness Cancer Growth and Metastasis ONA-XR Immune Evasion
View entire presentation